valcovir 450 mg filmom obložene tablete
aurobindo pharma (malta) limited, vault 14, level 2, valletta waterfront, floriana, malta - valganciclovirum - filmom obložena tableta - 450 mg - urbroj: jedna filmom obložena tableta sadrži valganciklovirklorid, što odgovara 450 mg valganciklovira
valganciklovir stada 450 mg filmom obložene tablete
stada d.o.o., hercegovačka 14, zagreb, hrvatska - valganciklovirklorid - filmom obložena tableta - 450 mg - urbroj: jedna tableta sadrži 496,3 mg valganciklovirklorida što odgovara 450 mg valganciklovira (kao slobodna baza)
grasustek
juta pharma gmbh - pegfilgrastim - neutropenija - Иммуностимуляторы, - smanjenje duljine trajanja neutropenije i incidencije febrilne neutropenije u odraslih bolesnika liječenih citotoksičnom kemoterapijom zbog zloćudne bolesti (uz iznimku kronične mijeloične leukemije i mijelodisplastičnog sindroma).
valcyte 450 mg filmom obložene tablete
cheplapharm arzneimittel gmbh, ziegelhof 24, greifswald, njemačka - valganciklovirklorid - filmom obložena tableta - 450 mg - urbroj: svaka tableta sadrži 496,3 mg valganciklovirklorida, što odgovara 450 mg valganciklovira (kao slobodne baze)
valcyte 50 mg/ml prašak za oralnu otopinu
cheplapharm arzneimittel gmbh, ziegelhof 24, greifswald, njemačka - valganciklovirklorid - prašak za oralnu otopinu - 50 mg/ml - urbroj: jedna boca sadrži 5,5 g valganciklovirklorida po 12 g praška za oralnu otopinu 1 ml rekonstituirane otopine sadrži 50 mg valganciklovira (u obliku klorida)
valganciklovir pliva 450 mg filmom obložene tablete
pliva hrvatska d.o.o., prilaz baruna filipovića 25, zagreb, hrvatska - valganciklovirklorid - filmom obložena tableta - 450 mg - urbroj: jedna filmom obložena tableta sadrži 450 mg valganciklovira, u obliku valganciklovirklorida
zolsketil pegylated liposomal
accord healthcare s.l.u. - doxorubicin hydrochloride, liposomal - ovarian neoplasms; sarcoma, kaposi; multiple myeloma - doxorubicin - zolsketil pegylated liposomal is a medicine used to treat the following types of cancer in adults:• breast cancer that has spread to other parts of the body in patients at risk of heart problems. zolsketil pegylated liposomal is used on its own for this disease;• advanced ovarian cancer in women whose previous treatment including a platinum-based cancer medicine has stopped working;• multiple myeloma (a cancer of the white blood cells in the bone marrow), in patients with progressive disease who have received at least one other treatment in the past and have already had, or are unsuitable for, a bone marrow transplantation. zolsketil pegylated liposomal is used in combination with bortezomib (another cancer medicine);• kaposi’s sarcoma in patients with aids who have a very damaged immune system. kaposi’s sarcoma is a cancer that causes abnormal tissue to grow under the skin, on moist body surfaces or on internal organs. zolsketil pegylated liposomal contains the active substance doxorubicin and is a ‘hybrid medicine’. this means that it is similar to a ‘reference medicine’ containing the same active substance called adriamycin. however, in zolsketil pegylated liposomal the active substance is enclosed in tiny fatty spheres called liposomes, whereas this is not the case for adriamycin.
valcyte 450mg film tableta
"hoffmann-la roche ltd" d.s.d. podgorica - valganciklovir - film tableta - 450mg
zinforo 600mg prašak za koncentrat za rastvor za infuziju
"evropa lek pharma" doo podgorica - ceftarolin fosamil - prašak za koncentrat za rastvor za infuziju - 600mg
zavicefta
pfizer ireland pharmaceuticals - avibactam sodium, ceftazidime pentahydrate - pneumonia, bacterial; soft tissue infections; pneumonia; urinary tract infections; gram-negative bacterial infections - antibakterijski lijekovi za sistemsku primjenu, - zavicefta is indicated in adults and paediatric patients aged 3 months and older for the treatment of the following infections:complicated intra-abdominal infection (ciai)complicated urinary tract infection (cuti), including pyelonephritishospital-acquired pneumonia (hap), including ventilator associated pneumonia (vap)treatment of patients with bacteraemia that occurs in association with, or is suspected to be associated with, any of the infections listed above. zavicefta is also indicated for the treatment of infections due to aerobic gram-negative organisms in adults and paediatric patients aged 3 months and older with limited treatment options. treba uzeti u obzir formalne preporuke za odgovarajuće korištenje antibakterijskih posrednika.